Navigation Links
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
Date:10/5/2009

ROCHESTER, N.Y., Oct. 5 /PRNewswire/ -- Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.

Tubilux is a privately held ophthalmic pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products primarily in Italy, and with distribution in approximately 30 other countries.

Under the terms of the agreement, Bausch & Lomb has acquired the company's ophthalmic pharmaceuticals portfolio, as well as its commercial and sales operations. Group Tubilux will retain its manufacturing operation, producing existing products for Bausch & Lomb under a multi-year contract.

"This agreement more than doubles our presence in the Italian ophthalmic pharmaceuticals market," said Charl van Zyl, head of Bausch & Lomb's Pharmaceuticals business for Europe, Middle East and Africa. "Bausch & Lomb is committed to expanding our portfolio offerings, and we believe that this investment will prove successful for the company, doctors and patients alike."

The acquired Tubilux portfolio includes products for dry eye relief (Oxyal, Lipimix, and Vitadrop); for glaucoma (Cebrolux and Timolux); for anti-infective use (Oftaquix); and for anti-inflammatory use (Fluaton).

"As a result of this transaction, Tubilux will strengthen its focus and presence in the ophthalmic pharmaceutical contract manufacturing sector, including ointments, gels and eye drop formats," said Emidio Fedeli, chief executive officer of Group Tubilux.

Sal Oppenheim Jr. & Cie. KGaA Milan Branch acted as the sole financial advisor of Group Tubilux in this transaction.

Financial terms of the agreement will not be made public.

About Bausch & Lomb

Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

SOURCE Bausch & Lomb


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
2. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
3. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
4. Robbins & Myers Announces Regular Quarterly Cash Dividend
5. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
6. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
9. U.S. Preventive Medicine Acquires Specialty Disease Management
10. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
11. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute lymphocytic Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Lymphocytic Leukemia epidemiology, Acute ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)... ACME Markets, Delaware County ... Councilman Dave White announced today the availability ... pharmacies across Delaware County . According ... has saved 26,463 lives nationwide over the past 20 years. Since ... were authorized to administer naloxone to overdose victims, 244 lives ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... May 06, 2016 , ... The Price Agency in ... support and assist the people of their local community. The agency pledges to ... community leaders. Their desire is to bring awareness to important local causes with ...
(Date:5/6/2016)... , ... May 06, 2016 , ... A wide variety of national pet product manufacturers, ... Garden and Safety Media Showcase Wednesday, May 18 from noon to 8 p.m. at New ... sneak peek at new and established home, garden, outdoor and safety pet products in today’s ...
(Date:5/6/2016)... , ... May 06, 2016 , ... Online HR/benefits platforms ... are changing the game for traditional brokers and health plans. “ The Rapid Emergence ... 17 webinar from Atlantic Information Services, Inc. (AIS), will offer an accurate picture of ...
(Date:5/6/2016)... ... May 06, 2016 , ... Expert ... . , Since launching in September, 2014 Sleepopolis has resided at Sleepopolis-mattress-reviews.com ... now include pillows, sheets, mattress toppers, bed frames, and more. , Founder and ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... This Mother’s ... for women everywhere. The 17th annual National Women’s Health Week takes place ... on Women’s Health are combining forces to empower women to make their health a ...
Breaking Medicine News(10 mins):